Nuclear GPCRS in cardiomyocytes: An insider's view of β-adrenergic receptor signaling

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 301, Issue 5, 2011, Pages

  Vaniotis, George ^a,b   Allen, Bruce G ^a,b,c   Hébert, Terence E ^c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

G protein coupled receptors; Nuclear signaling; Oligomerization; Signaling complexes

Indexed keywords

ADENYLATE CYCLASE; ANGIOTENSIN RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ARRESTIN; CALCIUM ION; CARVEDILOL; CELL SURFACE RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE; NORADRENALIN; PERTUSSIS TOXIN; PROTEIN KINASE B; RECEPTOR SUBTYPE; STAT3 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRICIRIBINE; TRITIUM;

ADRENERGIC SYSTEM; ANIMAL CELL; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART DISEASE; HEART FAILURE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DNA BINDING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL NUCLEUS; HEART DISEASES; HUMANS; LIGANDS; MYOCYTES, CARDIAC; PHENOTYPE; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION;

EID: 80455179690     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00657.2011     Document Type: Review

References (153)

1. Albert PR, Robillard L. G protein specificity: traffic direction required. Cell Signal 14: 407-418, 2002.
2. Azzi M, Charest PG, Angers S, Rousseau G, Kohout T, Bouvier M, Pineyro G. β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Natl Acad Sci USA 100: 11406-11411, 2003.
3. Baragli A, Grieco ML, Trieu P, Villeneuve LR, Hébert TE. Het-erodimers of adenylyl cyclases 2 and 5 show enhanced functional responses in the presence of Gas. Cell Signal 20: 480-492, 2008.
4. Barlow CA, Laishram RS, Anderson RA. Nuclear phosphoinositides: a signaling enigma wrapped in a compartmental conundrum. Trends Cell Biol 20: 25-35, 2010.
5. Boivin B, Chevalier D, Villeneuve LR, Rousseau E, Allen BG. Functional endothelin receptors are present on nuclei in cardiac ventricular myocytes. J Biol Chem 278: 29153-29163, 2003.
6. Boivin B, Lavoie C, Vaniotis G, Baragli A, Villeneuve LR, Ethier N, Trieu P, Allen BG, Hébert TE. Functional β-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes. Cardiovasc Res 71: 69-78, 2006.
7. Boivin B, Vaniotis G, Allen BG, Hébert TE. G protein-coupled receptors in and on the cell nucleus: a new signaling paradigm? J Recept Signal Transduct Res 28: 15-28, 2008.
8. Boivin B, Villeneuve LR, Farhat N, Chevalier D, Allen BG. Subcellular distribution of endothelin signaling pathway components in ventricular myocytes and heart: lack of preformed caveolar signalo-somes. J Mol Cell Cardiol 38: 665-676, 2005.
9. Breit A, Lagace M, Bouvier M. Hetero-oligomerization between β2-and β3-adrenergic receptors generates a β-adrenergic signaling unit with distinct functional properties. J Biol Chem 279: 28756-28765, 2004.
10. Bulenger S, Marullo S, Bouvier M. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol Sci 26: 131-137, 2005.
11. Burchett SA. In through the out door: nuclear localization of the regulators of G protein signaling. J Neurochem 87: 551-559, 2003.
12. Buu NT, Hui R, Falardeau P. Norepinephrine in neonatal rat ventricular myocytes: association with the cell nucleus and binding to nuclear α1- and β-adrenergic receptors. J Mol Cell Cardiol 25: 1037-1046, 1993.
13. Casey LM, Pistner AR, Belmonte SL, Migdalovich D, Stolpnik O, Nwakanma FE, Vorobiof G, Dunaevsky O, Matavel A, Lopes CM, Smrcka AV, Blaxall BC. Small molecule disruption of Gβγ signaling inhibits the progression of heart failure. Circ Res 107: 532-539, 2010.
14. Chen R, Mukhin YV, Garnovskaya MN, Thielen TE, Iijima Y, Huang C, Raymond JR, Ullian ME, Paul RV. A functional angiotensin II receptor-GFP fusion protein: evidence for agonist-dependent nuclear translocation. Am J Physiol Renal Physiol 279: F440-F448, 2000.
15. Chesley A, Lundberg MS, Asai T, Xiao RP, Ohtani S, Lakatta EG, Crow MT. The β2-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through Gi-dependent coupling to phosphatidylinositol 3'-kinase. Circ Res 87: 1172-1179, 2000.
16. Chidiac P, Hébert TE, Valiquette M, Dennis M, Bouvier M. Inverse agonist activity of β-adrenergic antagonists. Mol Pharmacol 45: 490-499, 1994.
17. Communal C, Singh K, Pimentel DR, Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the pj-adrenergic pathway. Circulation 98: 1329-1334, 1998.
18. Cook JL, Re RN. Intracellular accumulation and nuclear trafficking of angiotensin II and the angiotensin II type I receptor. In: The Local Cardiac Renin-Angiotensin Aldosterone System, edited by Frohlich ED and Re RN. New York: Springer, 2007, p. 29-41.
19. Cook LA, Schey KL, Wilcox MD, Dingus J, Ettling R, Nelson T, Knapp DR, Hildebrandt JD. Proteomic analysis of bovine brain G protein -y subunit processing heterogeneity. Mol Cell Proteomics 5: 671-685, 2006.
20. Dale LB, Seachrist JL, Babwah AV, Ferguson SS. Regulation of angiotensin II type 1A receptor intracellular retention, degradation, and recycling by Rab5, Rab7, and Rab11 GTPases. J Biol Chem 279: 13110-13118, 2004.
21. David M, Richer M, Mamarbachi AM, Villeneuve LR, Dupré DJ, Hébert TE. Interactions between GABA-B1 receptors and Kir 3 inwardly rectifying potassium channels. Cell Signal 18: 2172-2181, 2006.
22. Devic E, Xiang Y, Gould D, Kobilka B. β-Adrenergic receptor subtype-specific signaling in cardiac myocytes from (31 and β2 adrenoceptor knockout mice. Mol Pharmacol 60: 577-583, 2001.
23. Dong C, Filipeanu CM, Duvernay MT, Wu G. Regulation of G protein-coupled receptor export trafficking. Biochim Biophys Acta 1768: 853-870, 2007.
24. Drenan RM, Doupnik CA, Boyle MP, Muglia LJ, Huettner JE, Linder ME, Blumer KJ. Palmitoylation regulates plasma membrane-nuclear shuttling of R7BP, a novel membrane anchor for the RGS7 family. J Cell Biol 169: 623-633, 2005.
25. Dupré DJ, Baragli A, Rebois RV, Ethier N, Hébert TE. Signalling complexes associated with adenylyl cyclase II are assembled during their biosynthesis. Cell Signal 19: 481-489, 2007.
26. Dupré DJ, Hébert TE. Biosynthesis and trafficking of seven transmembrane receptor signalling complexes. Cell Signal 18: 1549-1559, 2006.
27. Dupré DJ, Robitaille M, Ethier N, Villeneuve LR, Mamarbachi AM, Hébert TE. Seven transmembrane receptor core signalling complexes are assembled prior to plasma membrane trafficking. J Biol Chem 281: 34561-34573, 2006.
28. Dupré DJ, Robitaille M, Rebois RV, Hébert TE. The role of Gβγ subunits in the organization, assembly, and function of GPCR signaling complexes. Annu Rev Pharmacol Toxicol 49: 31-56, 2009.
29. Duvernay MT, Zhou F, Wu G. A conserved motif for the transport of G protein-coupled receptors from the endoplasmic reticulum to the cell surface. J Biol Chem 279: 30741-30750, 2004.
30. Eisenhofer G. The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther 91: 35-62, 2001.
31. Evans BA, Sato M, Sarwar M, Hutchinson DS, Summers RJ. Ligand-directed signalling at β-adrenoceptors. Br J Pharmacol 159: 1022-1038, 2010.
32. Ferreiro I, Barragan M, Gubern A, Ballestar E, Joaquin M, Posas F. The p38 SAPK is recruited to chromatin via its interaction with transcription factors. J Biol Chem 285: 31819-31828, 2010.
33. Filipeanu CM, Zhou F, Claycomb WC, Wu G. Regulation of the cell-surface expression and function of angiotensin II type 1 receptor by Rab1-mediated ER-to-Golgi transport in cardiac myocytes. J Biol Chem 279: 41077-41084, 2004.
34. Frantz S, Fraccarollo D, Wagner H, Behr TM, Jung P, Angermann CE, Ertl G, Bauersachs J. Sustained activation of nuclear factor kB and activator protein 1 in chronic heart failure. Cardiovasc Res 57: 749-756, 2003.
35. Freyberg Z, Sweeney D, Siddhanta A, Bourgoin S, Frohman M, Shields D. Intracellular localization of phospholipase D1 in mammalian cells. Mol Biol Cell 12: 943-955, 2001.
36. Galandrin S, Bouvier M. Distinct signaling profiles of β1 and β2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-acti-vated protein kinase reveals the pluridimensionality of efficacy. Mol Pharmacol 70: 1575-1584, 2006.
37. Galandrin S, Oligny-Longpre G, Bouvier M. The evasive nature of drug efficacy: implications for drug discovery. Trends Pharmacol Sci 28: 423-430, 2007.
38. Garcia-Cazarin ML, Smith JL, Olszewski KA, McCune DF, Sim-merman LA, Hadley RW, Kraner SD, Piascik MT. The α1D-adren-ergic receptor is expressed intracellularly and coupled to increases in intracellular calcium and reactive oxygen species in human aortic smooth muscle cells. J Mol Signal 3: 6, 2008.
39. Gobeil F Jr, Bernier SG, Vazquez-Tello A, Brault S, Beauchamp MH, Quiniou C, Marrache AM, Checchin D, Sennlaub F, Hou X, Nader M, Bkaily G, Ribeiro-da-Silva A, Goetzl EJ, Chemtob S. Modulation of pro-inflammatory gene expression by nuclear lysophos-phatidic acid receptor type-1. J Biol Chem 278: 38875-38883, 2003.
40. Gobeil F Jr, Dumont I, Marrache AM, Vazquez-Tello A, Bernier SG, Abran D, Hou X, Beauchamp MH, Quiniou C, Bouayad A, Choufani S, Bhattacharya M, Molotchnikoff S, Ribeiro-Da-Silva A, Varma DR, Bkaily G, and Chemtob S. Regulation of eNOS expression in brain endothelial cells by perinuclear EP3 receptors. Circ Res 90: 682-689, 2002.
41. Goetzl EJ. Diverse pathways for nuclear signaling by G protein-coupled receptors and their ligands. FASEB J 21: 638-642, 2007.
42. Gressner OA, Lahme B, Siluschek M, Rehbein K, Weiskirchen R, Gressner AM. Intracrine signalling of activin A in hepatocytes upregu-lates connective tissue growth factor (CTGF/CCN2) expression. Liver Int 28: 1207-1216, 2008.
43. Grundemann D, Schechinger B, Rappold GA, Schomig E. Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1: 349-351, 1998.
44. Gudermann T, Kalkbrenner F, Schultz G. Diversity and selectivity of receptor-G protein interactions. Annu Rev Pharmacol Toxicol 36: 429-459, 1996.
45. Gudermann T, Schoneberg T, Schultz G. Functional and structural complexity of signal transduction via G-protein-coupled receptors. Annu Rev Neurosci 20: 399-427, 1997.
46. Hébert TE, Bouvier M. Structural and functional aspects of G protein-coupled receptor oligomerization. Biochem Cell Biol 76: 1-11, 1998.
47. Hepler JR. R7BP: a surprising new link between G proteins, RGS proteins, and nuclear signaling in the brain. Sci STKE 2005: pe38, 2005.
48. Higashi N, Kunimoto H, Kaneko S, Sasaki T, Ishii M, Kojima H, Nakajima K. Cytoplasmic c-Fos induced by the YXXQ-derived STAT3 signal requires the co-operative MEK/ERK signal for its nuclear translocation. Genes Cells 9: 233-242, 2004.
49. Hu S, Xie Z, Onishi A, Yu X, Jiang L, Lin J, Rho HS, Woodard C, Wang H, Jeong JS, Long S, He X, Wade H, Blackshaw S, Qian J, Zhu H. Profiling the human protein-DNA interactome reveals ERK2 as a transcriptional repressor of interferon signaling. Cell 139: 610-622, 2009.
50. Ito K, Akazawa H, Tamagawa M, Furukawa K, Ogawa W, Yasuda N, Kudo Y, Liao CH, Yamamoto R, Sato T, Molkentin JD, Kasuga M, Noda T, Nakaya H, Komuro I. PDK1 coordinates survival pathways and β-adrenergic response in the heart. Proc Natl Acad Sci USA 106: 8689-8694, 2009.
51. Jafri F, Ergul A. Nuclear localization of endothelin-converting enzyme-1: subisoform specificity. Arterioscler Thromb Vasc Biol 23: 2192-2196, 2003.
52. Johnson LR, Scott MG, Pitcher JA. G protein-coupled receptor kinase 5 contains a DNA-binding nuclear localization sequence. Mol Cell Biol 24: 10169-10179, 2004.
53. Jong YJ, Kumar V, O'Malley KL. Intracellular metabotropic glutamate receptor 5 (mGluR5) activates signaling cascades distinct from cell surface counterparts. J Biol Chem 284: 35827-35838, 2009.
54. Jonker JW, Schinkel AH. Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3). J Pharmacol Exp Ther 308: 2-9, 2004.
55. Kalkbrenner F, Degtiar VE, Schenker M, Brendel S, Zobel A, Heschler J, Wittig B, Schultz G. Subunit composition of Go proteins functionally coupling galanin receptors to voltage-gated calcium channels. EMBO J 14: 4728-4737, 1995.
56. Kenakin T. Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors. Trends Pharmacol Sci 28: 407-415, 2007.
57. Kenakin T. Functional selectivity and biased receptor signaling. J Pharmacol Exp Ther 336: 296-302, 2011.
58. Kenakin T. Functional selectivity through protean and biased agonism: who steers the ship? Mol Pharmacol 72: 1393-1401, 2007.
59. Kim CG, Park D, Rhee SG. The role of carboxyl-terminal basic amino acids in Gqa-dependent activation, particulate association, and nuclear localization of phospholipase C-β1. J Biol Chem 271: 21187-21192, 1996.
60. Kim IM, Tilley DG, Chen J, Salazar NC, Whalen EJ, Violin JD, Rockman HA. β-Blockers alprenolol and carvedilol stimulate β-arres-tin-mediated EGFR transactivation. Proc Natl Acad Sci USA 105: 14555-14560, 2008.
61. Kino T, Kozasa T, Chrousos GP. Statin-induced blockade of prenyla-tion alters nucleocytoplasmic shuttling of GTP-binding proteins -γ2 and β2 and enhances their suppressive effect on glucocorticoid receptor transcriptional activity. Eur J Clin Invest 35: 508-513, 2005.
62. Kino T, Tiulpakov A, Ichijo T, Chheng L, Kozasa T, Chrousos GP. G protein β interacts with the glucocorticoid receptor and suppresses its transcriptional activity in the nucleus. J Cell Biol 169: 885-896, 2005.
63. Kitanaka J, Kitanaka N, Takemura M, Wang XB, Hembree CM, Goodman NL, Uhl GR. Isolation and sequencing of a putative promoter region of the murine G protein β1 subunit (GNB1) gene. DNA Seq 13: 39-45, 2002.
64. Kleuss C, Hescheler J, Ewel C, Rosenthal W, Schultz G, Wittig B. Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents. Nature 353: 43-48, 1991.
65. Kleuss C, Scherubl H, Hescheler J, Schultz G, Wittig B. Different β-subunits determine G-protein interaction with transmembrane receptors. Nature 358: 424-426, 1992.
66. Kleuss C, Scherubl H, Hescheler J, Schultz G, Wittig B. Selectivity in signal transduction determined by -γ subunits of heterotrimeric G proteins. Science 259: 832-834, 1993.
67. Kolch W, Pitt A. Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. Nat Rev Cancer 10: 618-629, 2010.
68. 2+ release. J Biol Chem 283: 14072-14083, 2008.
69. Kuschel M, Zhou YY, Cheng H, Zhang SJ, Chen Y, Lakatta EG, Xiao RP. Gi protein-mediated functional compartmentalization of cardiac β2-adrenergic signaling. J Biol Chem 274: 22048-22052, 1999.
70. Lavine N, Ethier N, Oak JN, Pei L, Liu F, Trieu P, Rebois RV, Bouvier M, Hébert TE, Van Tol HH. G protein-coupled receptors form stable complexes with inwardly rectifying potassium channels and ad-enylyl cyclase. J Biol Chem 277: 46010-46019, 2002.
71. Lavoie C, Hébert TE. Pharmacological characterization of putative pS1-fi2-adrenergic receptor heterodimers. Can J Physiol Pharmacol 81: 186-195, 2003.
72. Lavoie C, Mercier JF, Salahpour A, Umapathy D, Breit A, Ville-neuve LR, Zhu WZ, Xiao RP, Lakatta EG, Bouvier M, Hébert TE. pS1/fi2-adrenergic receptor heterodimerization regulates β2-adrenergic receptor internalization and ERK signaling efficacy. J Biol Chem 277: 35402-35410, 2002.
73. Lee DK, Lanca AJ, Cheng R, Nguyen T, Ji XD, Gobeil F Jr, Chemtob S, George SR, O'Dowd BF. Agonist-independent nuclear localization of the apelin, angiotensin AT1, and bradykinin B2 receptors. J Biol Chem 279: 7901-7908, 2004.
74. Lee TH, Seng S, Sekine M, Hinton C, Fu Y, Avraham HK, Avraham S. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/ FLT1. PLoS Med 4: e186, 2007.
75. 2+ channel regulation in adult rat ventricular myocytes: role of phosphodiesterases. Circ Res 102: 1091-1100, 2008.
76. Liu Z, Fisher RA. RGS6 interacts with DMAP1 and DNMT1 and inhibits DMAP1 transcriptional repressor activity. J Biol Chem 279: 14120-14128, 2004.
77. Lopez-Gimenez JF, Canals M, Pediani JD, Milligan G. The a1b-adrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery, and function. Mol Pharmacol 71: 1015-1029, 2007.
78. Lorenz K, Schmitt JP, Schmitteckert EM, Lohse MJ. A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy. Nat Med 15: 75-83, 2009.
79. Lorenz K, Schmitt JP, Vidal M, Lohse MJ. Cardiac hypertrophy: targeting Raf/MEK/ERK1/2-signaling. Int J Biochem Cell Biol 41: 2351-2355, 2009.
80. Lu D, Yang H, Shaw G, Raizada MK. Angiotensin II-induced nuclear targeting of the angiotensin type 1 (AT1) receptor in brain neurons. Endocrinology 139: 365-375, 1998.
81. Lucero HA, Kintsurashvili E, Marketou ME, Gavras H. Cell signaling, internalization, and nuclear localization of the angiotensin converting enzyme in smooth muscle and endothelial cells. J Biol Chem 285: 5555-5568, 2010.
82. Luttrell LM, Gesty-Palmer D. Beyond desensitization: physiological relevance of arrestin-dependent signaling. Pharmacol Rev 62: 305-330, 2010.
83. Lymperopoulos A, Rengo G, Funakoshi H, Eckhart AD, Koch WJ. Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure. Nat Med 13: 315-323, 2007.
84. Malnou CE, Salem T, Brockly F, Wodrich H, Piechaczyk M, Jariel-Encontre I. Heterodimerization with Jun family members regulates c-Fos nucleocytoplasmic traffic. J Biol Chem 282: 31046-31059, 2007.
85. Marrache AM, Gobeil F Jr, Bernier SG, Stankova J, Rola-Pleszc-zynski M, Choufani S, Bkaily G, Bourdeau A, Sirois MG, Vazquez-Tello A, Fan L, Joyal JS, Filep JG, Varma DR, Ribeiro-Da-Silva A, Chemtob S. Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor. J Immunol 169: 6474-6481, 2002.
86. Mercier JF, Salahpour A, Angers S, Breit A, Bouvier M. Quantitative assessment of β1 - and β2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem 277: 44925-44931, 2002.
87. Milligan G. G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function. Br J Pharmacol 158: 5-14, 2009.
88. Milligan G. The role of dimerisation in the cellular trafficking of G-protein-coupled receptors. Curr Opin Pharmacol 10: 23-29, 2010.
89. Miyamoto S, Rubio M, Sussman MA. Nuclear and mitochondrial signalling Akts in cardiomyocytes. Cardiovasc Res 82: 272-285, 2009.
90. Moens AL, Leyton-Mange JS, Niu X, Yang R, Cingolani O, Arken-bout EK, Champion HC, Bedja D, Gabrielson KL, Chen J, Xia Y, Hale AB, Channon KM, Halushka MK, Barker N, Wuyts FL, Kaminski PM, Wolin MS, Kass DA, Barouch LA. Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the β3-adrenoreceptor. J Mol Cell Cardiol 47: 576-585, 2009.
91. Noma T, Lemaire A, Naga Prasad SV, Barki-Harrington L, Tilley DG, Chen J, Le Corvoisier P, Violin JD, Wei H, Lefkowitz RJ, Rockman HA. β-Arrestin-mediated β1-adrenergic receptor transactiva-tion of the EGFR confers cardioprotection. J Clin Invest 117: 2445-2458, 2007.
92. 2+ changes in heterologous cell types and neurons. J Biol Chem 278: 28210-28219, 2003.
93. Park JG, Muise A, He GP, Kim SW, Ro HS. Transcriptional regulation by the -γ5 subunit of a heterotrimeric G protein during adipogenesis. EMBO J 18: 4004-4012, 1999.
94. Patel CB, Noor N, Rockman HA. Functional selectivity in adrenergic and angiotensin signaling systems. Mol Pharmacol 78: 983-992, 2010.
95. Pétrin D, Hébert TE. Imaging-based approaches to understanding G protein-coupled receptor signalling complexes. Methods Mol Biol 756: 37-60, 2011.
96. Picht E, Zima AV, Shannon TR, Duncan AM, Blatter LA, Bers DM. Dynamic calcium movement inside cardiac sarcoplasmic reticulum during release. Circ Res 108: 847-856, 2011.
97. Pokholok DK, Zeitlinger J, Hannett NM, Reynolds DB, Young RA. Activated signal transduction kinases frequently occupy target genes. Science 313: 533-536, 2006.
98. Prinster SC, Hague C, Hall RA. Heterodimerization of G protein-coupled receptors: specificity and functional significance. Pharmacol Rev 57: 289-298, 2005.
99. Rajagopal K, Lefkowitz RJ, Rockman HA. When 7 transmembrane receptors are not G protein-coupled receptors. J Clin Invest 115: 2971-2974, 2005.
100. Re M, Pampillo M, Savard M, Dubuc C, McArdle CA, Millar RP, Conn PM, Gobeil F Jr, Bhattacharya M, Babwah AV. The human gonadotropin releasing hormone type I receptor is a functional intracellular GPCR expressed on the nuclear membrane. PLoS One 5: e11489, 2010.
101. Re R. Intracellular renin-angiotensin system: the tip of the intracrine physiology iceberg. Am J Physiol Heart Circ Physiol 293: H905-H906, 2007.
102. Rebois RV, Hébert TE. Protein complexes involved in heptahelical receptor-mediated signal transduction. Receptors Channels 9: 169-194, 2003.
103. Rebois RV, Robitaille M, Gales C, Dupré DJ, Baragli A, Trieu P, Ethier N, Bouvier M, Hébert TE. Heterotrimeric G proteins form stable complexes with adenylyl cyclase and Kir3.1 channels in living cells. J Cell Sci 119: 2807-2818, 2006.
104. Robben JH, Kortenoeven ML, Sze M, Yae C, Milligan G, Oorschot VM, Klumperman J, Knoers NV, Deen PM. Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists. Proc Natl Acad Sci USA 106: 12195-12200, 2009.
105. Robillard L, Ethier N, Lachance M, Hébert TE. Gβγ subunit combinations differentially modulate receptor and effectors coupling in vivo. Cell Signal 12: 673-682, 2000.
106. Robishaw JD, Guo ZP, Wang Q. Ribozymes as tools for suppression of G protein -y subunits. Methods Mol Biol 237: 169-180, 2003.
107. Robitaille M, Gora S, Wang Y, Goupil E, Pétrin D, Del Duca D, Villeneuve LR, Allen BG, Laporte SA, Bernard DJ, Hébert TE. Gβγ is a negative regulator of AP-1 mediated transcription. Cell Signal 22: 1254-1266, 2010.
108. Robitaille M, Ramakrishnan N, Baragli A, Hébert TE. Intracellular trafficking and assembly of specific Kir3 channel/G protein complexes. Cell Signal 21: 488-501, 2009.
109. Rojkova AM, Woodard GE, Huang TC, Combs CA, Zhang JH, Simonds WF. G γ subunit-selective G protein β5 mutant defines regulators of G protein signaling protein binding requirement for nuclear localization. J Biol Chem 278: 12507-12512, 2003.
110. Saito T, Giaid A. Cyclooxygenase-2 and nuclear factor-kB in myocardium of end stage human heart failure. Congest Heart Fail 5: 222-227, 1999.
111. Salahpour A, Angers S, Mercier JF, Lagace M, Marullo S, Bouvier M. Homodimerization of the β2-adrenergic receptor as a prerequisite for cell surface targeting. J Biol Chem 279: 33390-33397, 2004.
112. Samama P, Pei G, Costa T, Cotecchia S, Lefkowitz RJ. Negative antagonists promote an inactive conformation of the β2-adrenergic receptor. Mol Pharmacol 45: 390-394, 1994.
113. Sastri M, Barraclough DM, Carmichael PT, Taylor SS. A-kinase-interacting protein localizes protein kinase A in the nucleus. Proc Natl Acad Sci USA 102: 349-354, 2005.
114. Sato M, Horinouchi T, Hutchinson DS, Evans BA, Summers RJ. Ligand-directed signaling at the β-adrenoceptor produced by 3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-pro- pan ol oxalate (SR59230A) relative to receptor agonists. Mol Pharmacol 72: 1359-1368, 2007.
115. Sato M, Hutchinson DS, Evans BA, Summers RJ. The β-adrenoceptor agonist 4-[[(Hexylamino)carbonyl]amino]-N-[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphe noxy)propyl]amino]ethyl]-phenyl]-benzenesulfonamide (L755507) and antagonist (S)-N-[4-[2-[[3-[3-(acetamidomethyl)phenoxy]-2-hydroxypropyl]amino]-ethy l] phenyl]benzenesulfonamide (L748337) activate different signaling pathways in Chinese hamster ovary-K1 cells stably expressing the human β-adrenoceptor. Mol Pharmacol 74: 1417-1428, 2008.
116. Savard M, Barbaz D, Belanger S, Muller-Esterl W, Bkaily G, D'Orleans-Juste P, Cote J, Bovenzi V, Gobeil F Jr. Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation. J Cell Physiol 216: 234-244, 2008.
117. Schievella AR, Regier MK, Smith WL, Lin LL. Calcium-mediated translocation of cytosolic phospholipase A2 to the nuclear envelope and endoplasmic reticulum. J Biol Chem 270: 30749-30754, 1995.
118. Schulze W, Buchwalow IB. Adenylyl cyclase in the heart: an enzymo-cytochemical and immunocytochemical approach. Microsc Res Tech 40: 473-478, 1998.
119. Schwindinger WF, Betz KS, Giger KE, Sabol A, Bronson SK, Robishaw JD. Loss of G protein -γ7 alters behavior and reduces striatal a(olf) level and cAMP production. J Biol Chem 278: 6575-6579, 2003.
120. Scott MG, Le Rouzic E, Perianin A, Pierotti V, Enslen H, Benichou S, Marullo S, Benmerah A. Differential nucleocytoplasmic shuttling of β-arrestins. Characterization of a leucine-rich nuclear export signal in β-arrestin2. J Biol Chem 277: 37693-37701, 2002.
121. Seachrist JL, Anborgh PH, Ferguson SS. β2-Adrenergic receptor internalization, endosomal sorting, and plasma membrane recycling are regulated by rab GTPases. J Biol Chem 275: 27221-27228, 2000.
122. Seachrist JL, Laporte SA, Dale LB, Babwah AV, Caron MG, Anborgh PH, Ferguson SS. Rab5 association with the angiotensin II type 1A receptor promotes Rab5 GTP binding and vesicular fusion. J Biol Chem 277: 679-685, 2002.
123. Smotrys JE, Linder ME. Palmitoylation of intracellular signaling proteins: regulation and function. Annu Rev Biochem 73: 559-587, 2004.
124. Spiegelberg BD, Hamm HE. G βγ binds histone deacetylase 5 (HDAC5) and inhibits its transcriptional co-repression activity. J Biol Chem 280: 41769-41776, 2005.
125. Steinberg SF. P2-Adrenergic receptor signaling complexes in cardiomy-ocyte caveolae/lipid rafts. J Mol Cell Cardiol 37: 407-415, 2004.
126. Steinberg SF. The molecular basis for distinct β-adrenergic receptor subtype actions in cardiomyocytes. Circ Res 85: 1101-1111, 1999.
127. Steinberg SF, Brunton LL. Compartmentation of G protein-coupled signaling pathways in cardiac myocytes. Annu Rev Pharmacol Toxicol 41: 751-773, 2001.
128. Sun Y, Yamauchi J, Kaziro Y, Itoh H. Activation of c-fos promoter by Gβγ -mediated signaling: involvement of Rho and c-Jun N-terminal kinase. J Biochem 125: 515-521, 1999.
129. Tadevosyan A, Maguy A, Villeneuve LR, Babin J, Bonnefoy A, Allen BG, Nattel S. Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression. J Biol Chem 285: 22338-22349, 2010.
130. Tanos T, Marinissen MJ, Leskow FC, Hochbaum D, Martinetto H, Gutkind JS, Coso OA. Phosphorylation of c-Fos by members of the p38 MAPK family. Role in the AP-1 response to UV light. J Biol Chem 280: 18842-18852, 2005.
131. Terrillon S, Bouvier M. Roles of G-protein-coupled receptor dimeriza-tion. EMBO Rep 5: 30-34, 2004.
132. Tilley DG, Kim IM, Patel PA, Violin JD, Rockman HA. β-Arrestin mediates fi1-adrenergic receptor-epidermal growth factor receptor interaction and downstream signaling. J Biol Chem 284: 20375-20386, 2009.
133. Turjanski AG, Vaque JP, Gutkind JS. MAP kinases and the control of nuclear events. Oncogene 26: 3240-3253, 2007.
134. Vaniotis G, Del Duca D, Trieu P, Rohlicek CV, Hébert TE, Allen BG. Nuclear β-adrenergic receptors modulate gene expression in adult rat heart. Cell Signal 23: 89-98, 2011.
135. Wang P, Wu Y, Ge X, Ma L, Pei G. Subcellular localization of pj-arrestins is determined by their intact N domain and the nuclear export signal at the C terminus. J Biol Chem 278: 11648-11653, 2003.
136. Wang Q, Jolly JP, Surmeier JD, Mullah BM, Lidow MS, Bergson CM, Robishaw JD. Differential dependence of the D1 and D5 dopamine receptors on the G protein -γ7 subunit for activation of adenylylcyclase. J Biol Chem 276: 39386-39393, 2001.
137. Wang Q, Mullah B, Hansen C, Asundi J, Robishaw JD. Ribozyme-mediated suppression of the G protein -γ7 subunit suggests a role in hormone regulation of adenylyl cyclase activity. J Biol Chem 272: 26040-26048, 1997.
138. Wang Q, Mullah BK, Robishaw JD. Ribozyme approach identifies a functional association between the G protein fi1y7 subunits in the β-adrenergic receptor signaling pathway. J Biol Chem 274: 17365-17371, 1999.
139. Watson PH, Fraher LJ, Natale BV, Kisiel M, Hendy GN, Hodsman AB. Nuclear localization of the type 1 parathyroid hormone/parathyroid hormone-related peptide receptor in MC3T3-E1 cells: association with serum-induced cell proliferation. Bone 26: 221-225, 2000.
140. Weiss JM, Morgan PH, Lutz MW, Kenakin TP. The cubic ternary complex receptor-occupancy model. I. Model description. J Theor Biol 178: 151-167, 1996.
141. Willard FS, Crouch MF. Nuclear and cytoskeletal translocation and localization of heterotrimeric G-proteins. Immunol Cell Biol 78: 387-394, 2000.
142. Wright CD, Chen Q, Baye NL, Huang Y, Healy CL, Kasinathan S, O'Connell TD. Nuclear a1-adrenergic receptors signal activated ERK localization to caveolae in adult cardiac myocytes. Circ Res 103: 992-1000, 2008.
143. Xiao RP, Avdonin P, Zhou YY, Cheng H, Akhter SA, Eschenhagen T, Lefkowitz RJ, Koch WJ, Lakatta EG. Coupling of β-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. Circ Res 84: 43-52, 1999.
144. Xiao RP, Cheng H, Zhou YY, Kuschel M, Lakatta EG. Recent advances in cardiac β2-adrenergic signal transduction. Circ Res 85: 1092-1100, 1999.
145. Xiao RP, Ji X, Lakatta EG. Functional coupling of the β-adrenoceptor to a pertussis toxin- sensitive G protein in cardiac myocytes. Mol Pharmacol 47: 322-329, 1995.
146. Xiao RP, Zhu W, Zheng M, Chakir K, Bond R, Lakatta EG, Cheng H. Subtype-specific β-adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends Pharmacol Sci 25: 358-365, 2004.
147. Yamamoto S, Kawamura K, James TN. Intracellular distribution of adenylate cyclase in human cardiocytes determined by electron microscopic cytochemistry. Microsc Res Tech 40: 479-487, 1998.
148. Yi XP, Gerdes AM, Li F. Myocyte redistribution of GRK2 and GRK5 in hypertensive, heart-failure-prone rats. Hypertension 39: 1058-1063, 2002.
149. Yi XP, Zhou J, Baker J, Wang X, Gerdes AM, Li F. Myocardial expression and redistribution of GRKs in hypertensive hypertrophy and failure. Anat Rec A Discov Mol Cell Evol Biol 282: 13-23, 2005.
150. Yuen JW, Poon LS, Chan AS, Yu FW, Lo RK, Wong YH. Activation of STAT3 by specific Ga subunits and multiple Gβγ dimers. Int J Biochem Cell Biol 42: 1052-1059, 2010.
151. Zhang JH, Barr VA, Mo Y, Rojkova AM, Liu S, Simonds WF. Nuclear localization of G protein β5 and regulator of G protein signaling 7 in neurons and brain. J Biol Chem 276: 10284-10289, 2001.
152. Zhu WZ, Chakir K, Zhang S, Yang D, Lavoie C, Bouvier M, Hebert TE, Lakatta EG, Cheng H, Xiao RP. Heterodimerization of β1- and β-adrenergic receptor subtypes optimizes β-adrenergic modulation of cardiac contractility. Circ Res 97: 244-251, 2005.
153. Zhuo JL, Imig JD, Hammond TG, Orengo S, Benes E, Navar LG. Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor. Hypertension 39: 116-121, 2002.